Pipeline
Program
Discovery
Pre-Clinical
IND-Enabling
Phase 1
Phase 2
Phase 3
ImmCelz®
Learn More →
Reprogrammed Cells
Learn More →
Intellectual Property
This IP portfolio positions us at the forefront of the regenerative medicine industry (set to grow to $79.23 Billion by 2026). We plan to commercialize these products on our own and in collaboration with strategic partners.
Area
Application/Patent #
Description
Immunology
63395252
Prevention and Treatment of Reproductive Failure by Regenerative Cells and Adjuvants
Immunology
63351330
Generation of Conditioned Media from Inducible Pluripotent Stem Cell Derived Endothelial Progenitor Cells
Immunology
63389091
Overcoming TNF-alpha Blockade Resistance in Rheumatoid Arthritis by Regenerative T Regulatory Cell Therapy
Immunology
63248324
Suppression of Diabetes Using Exosomes from Stem Cell Programmed Myeloid Cells
Immunology
63270678
Regenerative T Regulatory Cells
Immunology
63351330
Generation of Conditioned Media from Inducible Pluripotent Stem Cell Derived Mesenchymal Stem Cells
Immunology
63297883
Regenerative CAR-T Cells
Immunology
63123380
Induction of Infectious Tolerance by Ex Vivo Reprogrammed Immune Cells
Immunology
63395836
Prevention and Treatment of Hair Loss
Endocrinology
63338417
Prevention of Menopause Associated Osteoporosis by Intra-ovarian Administration of Regenerative Cells
Endocrinology
63349976
Cellular Regenerative Therapeutics for Enhancement/Restoration of Endometrial Function
Immunology
10,792,310
Methods for Treatment of Premature Ovarian Failure and Ovarian Aging Using Regenerative Cells
Endocrinology
16759671
Augmentation of Fertility by Platelet Rich Plasma
Immunology
63343846
Repair of Ovarian Damage and Dampening of Inflammatory Microenvironment by Administration of Monocytic-Granulocytic Progenitors with Immune Modulatory Activities
Immunology
63340454
Immunological Enhancement of Stem Cell Activity in Treatment of Ovarian Failure
Immunology
63340450
Protection from Ovarian Failure by Low Dose Interleukin-2 Administration
Immunology
63340447
Stimulation of Ovarian Function Subsequent to Chemotherapy
Immunology
63343832
Cytokine Primed Regenerative Cells for Treatment of Ovarian Failure
Immunology
63343841
Degenerating Ovarian Microenvironment Resistant Mesenchymal Stem Cells
Immunology
15617813
Adipose Derived Immunotherapy of Recurrent Spontaneous Abortion
Immunology
63349297
Gene Therapeutics for Enhancement/Restoration of Endometrial Function
Immunology
15702735
Inducing and Accelerating Post-Stroke Recovery by Administration of Amniotic Fluid Derived Stem Cells
Immunology
15987739
Generation of Autologous Immune Modulatory Cells for Treatment of Neurological Conditions
Immunology
63313313
Methods for Quantifying Potency of Regenerative Immunotherapies
Urology
15590668
Methods of Treating Erectile Dysfunction
Immunology
8,372,797
Treatment of Erectile Dysfunction by Stem Cell Therapy
Urology
16799656
Extracorporeal Shock Wave Ultrasound for Enhancement of Regenerative Activities in Erectile Dysfunction
Immunology
63302228
Regenerative Cell Therapy for Viral Induced Sexual Dysfunction
Immunology
63331179
Enhancement of Cartilage Regenerative Activity of Stem Cell Populations Based on Reduction of Intra-Articular Cellular Material
Immunology
9,598,673
Treatment of Disc Degenerative Disease
Immunology
10,842,815
Perispinal Perfusion by Administration of T regulatory Cells Alone or in Combination with Angiogenic Cell Therapies
Immunology
63331183
Enhancement of Stem Cell Therapy for Cartilage Degeneration by Anti-Oxidant Pre-Conditioning
Immunology
63331186
Treatment of Cartilage Degeneration Using Myeloid Suppressor Cells and Exosomes Derived Thereof
Diagnostics
63340828
Exosome Based Assays for Determining Candidates for Osteoarthritis Stem Cell Therapy
Diagnostics
63338416
Cytokine Based Assessment of Recipient Ability to Respond to Stem Cell Therapy for Cartilage Regeneration
Immunology
63297876
Chimeric Antigen Receptor Regenerative Gamma Delta T Cells
Immunology
17585356
Treatment of Kidney Failure using Ex Vivo Reprogrammed Immune Cells
Immunology
17559985
Treatment of Liver Failure by Ex Vivo Reprogrammed Immune Cells
Immunology
17559970
Treatment of Heart Failure and/or Post Infarct Pathological Remodeling by Ex Vivo Reprogrammed Immune Cells
Immunology
63138776
Treatment of Diabetes Using Immune Cells Reprogrammed Ex Vivo by Regenerative Cells
Immunology
63208249
Prevention and/or Treatment of Type 1 Diabetes by Augmentation of Myeloid Suppressor Cell Activity
Immunology
63223245
Therapeutic Monocytic Lineage Cells
Immunology
63313313
Methods for Quantifying Potency of Regenerative Immunotherapies
Immunology
63414823
Treatment of Diabetes by Enhancement of Pancreatic Islet Engraftment Through Regenerative Immune Modulation
Immunology
63390759
Treatment of limb Ischemia by Bone Marrow Stem Cells And Modification of Diseased Microenvironment
Immunology
63391865
Potentiation of Bone Marrow Cell Activity by Co-administration with Oxytocin
Immunology
63395839
Prophylaxis and Treatment of Orthopox Viruses Using Regenerative cells and Products Thereof
Immunology
63395834
Prevention of Space Travel Associated Bone Density Loss by Regenerative Cell Populations
Connect With Us
Interested in learning more?
Connect with us now by filling out our form on our contact page.
